Form4insider filings, from the source

SEC Form 4 · accession 0000905718-17-000413

Kindred Biosciences, Inc. · KIN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Mar 24, 2017
Accepted (ET)
Mar 28, 2017 · 5:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001561743

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Equity SwapF2,F1,F3—Mar 24, 2017J168,213AMar 24, 2017Jun 4, 2018Common Stock, $0.0001 par value per share168,213168,213I
Equity SwapF4,F1,F5—Mar 27, 2017J31,787AMar 27, 2017Jun 4, 2018Common Stock, $0.0001 par value per share31,78731,787I

Explanation of responses